Rumbach L - Search Results

1

Interferon gamma, IL2, IL4, IL10 and TNFalpha secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody.

Lopez E, Racadot E, Bataillard M, Berger E, Rumbach L. Lopez E, et al. Among authors: rumbach l. Autoimmunity. 1999;29(2):87-92. doi: 10.3109/08916939908995377. Autoimmunity. 1999. PMID: 10433069 Free article.

2

[Open therapeutic trial of anti-T CD4 monoclonal antibody in multiple sclerosis].

Rumbach L, Racadot E, Bataillard M, Galmiche J, Henlin JL, Trutmann M, Ziegler F, Wijdenes J. Rumbach L, et al. Rev Neurol (Paris). 1994 Jun-Jul;150(6-7):418-24. Rev Neurol (Paris). 1994. PMID: 7747009 Clinical Trial. French.

3

Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients.

Racadot E, Rumbach L, Bataillard M, Galmiche J, Henlin JL, Truttmann M, Herve P, Wijdenes J. Racadot E, et al. Among authors: rumbach l. J Autoimmun. 1993 Dec;6(6):771-86. doi: 10.1006/jaut.1993.1063. J Autoimmun. 1993. PMID: 8155256 Clinical Trial.

4

Biological assessment and MRI monitoring of the therapeutic efficacy of a monoclonal anti-T CD4 antibody in multiple sclerosis patients.

Rumbach L, Racadot E, Armspach JP, Namer IJ, Bonneville JF, Wijdenes J, Marescaux C, Herve P, Chambron J. Rumbach L, et al. Mult Scler. 1996 Feb;1(4):207-12. Mult Scler. 1996. PMID: 9345436 Clinical Trial.

5

[New therapeutic strategies in multiple sclerosis].

Berger E, Rumbach L. Berger E, et al. Among authors: rumbach l. Rev Med Interne. 1999 Aug;20 Suppl 3:346s-350s. doi: 10.1016/s0248-8663(99)80507-4. Rev Med Interne. 1999. PMID: 10480185 Review. French.

6

Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience.

Herve P, Racadot E, Wendling D, Rumbach L, Tiberghien P, Cahn JY, Flesch M, Wijdenes J. Herve P, et al. Among authors: rumbach l. Immunol Rev. 1992 Oct;129:31-55. doi: 10.1111/j.1600-065x.1992.tb01418.x. Immunol Rev. 1992. PMID: 1464420 Review. No abstract available.

7

[Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].

Nollet S, Berger E, Deconinck E, Baldauf E, Rumbach L. Nollet S, et al. Among authors: rumbach l. Rev Neurol (Paris). 2006 Feb;162(2):195-9. doi: 10.1016/s0035-3787(06)74999-2. Rev Neurol (Paris). 2006. PMID: 16518259 French.

8

Olfactory dysfunction in multiple sclerosis: evidence of a decrease in different aspects of olfactory function.

Rolet A, Magnin E, Millot JL, Berger E, Vidal C, Sileman G, Rumbach L. Rolet A, et al. Among authors: rumbach l. Eur Neurol. 2013;69(3):166-70. doi: 10.1159/000345482. Epub 2012 Dec 19. Eur Neurol. 2013. PMID: 23257936

9

Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis.

Tataru N, Vidal C, Decavel P, Berger E, Rumbach L. Tataru N, et al. Among authors: rumbach l. Neuroepidemiology. 2006;27(1):28-32. doi: 10.1159/000094233. Epub 2006 Jun 27. Neuroepidemiology. 2006. PMID: 16804331

10

Seizures and epilepsy following strokes: recurrence factors.

Berges S, Moulin T, Berger E, Tatu L, Sablot D, Challier B, Rumbach L. Berges S, et al. Among authors: rumbach l. Eur Neurol. 2000;43(1):3-8. doi: 10.1159/000008120. Eur Neurol. 2000. PMID: 10601801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters